MOTTA, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 18.682
EU - Europa 1.466
AS - Asia 1.002
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 3
AF - Africa 2
Totale 21.191
Nazione #
US - Stati Uniti d'America 18.669
SG - Singapore 410
UA - Ucraina 255
CN - Cina 221
IT - Italia 219
KR - Corea 209
DE - Germania 199
IE - Irlanda 178
SE - Svezia 142
HK - Hong Kong 105
RU - Federazione Russa 98
FR - Francia 92
GB - Regno Unito 91
PL - Polonia 79
FI - Finlandia 50
BR - Brasile 16
JP - Giappone 16
BE - Belgio 13
CZ - Repubblica Ceca 13
EU - Europa 13
NL - Olanda 10
CA - Canada 9
ES - Italia 8
IN - India 7
AT - Austria 6
AR - Argentina 4
RO - Romania 4
TR - Turchia 4
VN - Vietnam 4
AU - Australia 3
ID - Indonesia 3
IQ - Iraq 3
IR - Iran 3
UZ - Uzbekistan 3
DK - Danimarca 2
DM - Dominica 2
IL - Israele 2
KG - Kirghizistan 2
MX - Messico 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
GR - Grecia 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
MY - Malesia 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
Totale 21.191
Città #
Woodbridge 5.496
Wilmington 5.162
Houston 4.458
Fairfield 616
Ann Arbor 410
Singapore 360
Chandler 347
Ashburn 249
Seattle 228
Jacksonville 207
Cambridge 185
Dublin 169
Medford 135
Dearborn 104
Hong Kong 103
Rome 87
Beijing 82
Kraków 78
Santa Clara 78
Lawrence 64
New York 62
Council Bluffs 61
San Diego 46
Zhengzhou 44
Norwalk 29
Menlo Park 19
Milan 19
Moscow 19
Palo Alto 19
Munich 18
Mülheim 17
Hangzhou 14
London 14
Redwood City 14
Brno 13
Brussels 13
Hefei 12
Boardman 11
Mountain View 11
University Park 11
Seoul 9
Kunming 8
Madrid 8
Nanjing 8
Verona 8
Los Angeles 6
Mcallen 6
Saint Petersburg 6
Vienna 6
Falls Church 5
Jinan 5
Monmouth Junction 5
Philadelphia 5
Shanghai 5
São Paulo 5
Tokyo 5
Clearwater 4
Ferrara 4
Guangzhou 4
Helsinki 4
Hounslow 4
New Bedfont 4
Redmond 4
San Francisco 4
Slough 4
Stafford 4
Amsterdam 3
Atlanta 3
Bielefeld 3
Bologna 3
Fuzhou 3
Hanoi 3
Jakarta 3
Kilburn 3
Nanchang 3
Nuremberg 3
Palagiano 3
Phoenix 3
Rodigo 3
San Mateo 3
Tehran 3
Torre Annunziata 3
Wenzhou 3
Acton 2
Berlin 2
Canberra 2
Catania 2
Chiswick 2
Chongqing 2
Cologne 2
Frankfurt am Main 2
Hyderabad 2
Indiana 2
Istanbul 2
Leipzig 2
Miami 2
Montréal 2
Naples 2
Oslo 2
Ottawa 2
Totale 19.309
Nome #
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 483
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 461
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 460
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease 452
Subclinical central inflammation is risk for RIS and CIS conversion to MS 445
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 438
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 437
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 435
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 428
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 422
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 422
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 415
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 415
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 412
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 411
Inflammation inhibits GABA transmission in multiple sclerosis 410
Disability and its progression can be objectively measured in multiple sclerosis 409
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 407
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 405
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 405
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 405
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 402
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 398
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 396
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 392
Neural stem cell transplantation promotes post-ischemic neuronal plasticity by regulating the expression of glutamate transporters 390
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation 386
Plasmacytoid dendritic cells induce an immunoregulatory T helper 9 profile in multiple sclerosis 384
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System 381
The autonomic balance predicts cardiac responses after the first dose of fingolimod 380
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis 377
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis 376
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis 368
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 368
Endovascular Stroke Treatment of Acute Tandem Occlusion: A Single-Center Experience 368
Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab 367
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis 366
Efficacy and Safety of Mechanical Thrombectomy in Older Adults with Acute Ischemic Stoke 363
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids 359
Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis 355
CT angiography-based collateral flow and time to reperfusion are strong predictors of outcome in endovascular treatment of patients with stroke 355
Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum 351
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 345
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 341
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 331
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 331
Pretreatment predictors of malignant evolution in patients with ischemic stroke undergoing mechanical thrombectomy 328
CT angiography ASPECTS predicts outcome much better than noncontrast CT in patients with stroke treated endovascularly 325
Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset 321
Proposed chronic cerebrospinal venous insufficienty criteria do not predict multiple sclerosis risk or severity 315
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 300
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 258
Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia 169
Heparin during endovascular stroke treatment seems safe 161
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients. 153
Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study 138
Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer's disease carrying apolipoprotein E4 genotype 129
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial 116
Clinical and histological study of a xenogenic bone substitute used as a filler in postextractive alveolus 108
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease 101
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia 69
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias 57
Isolated amyloid-β pathology is associated with preserved cortical plasticity in APOE4 Alzheimer's disease patients 57
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype 51
Functional correlates of microglial and astrocytic activity in symptomatic sporadic Alzheimer's disease: a CSF/18F-FDG-PET study 38
Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial 36
Decreased Frontal Gamma Activity in Alzheimer Disease Patients 21
Intermittent cerebellar theta burst stimulation improves visuo-motor learning in stroke patients: a pilot study 11
Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in the Alzheimer's disease continuum 10
Improving visuo-motor learning with cerebellar theta burst stimulation: behavioral and neurophysiological evidence 9
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study 9
null 3
Biobanking for Neurodegenerative Diseases: Challenge for Translational Research and Data Privacy 2
Blood–brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease 1
Totale 21.503
Categoria #
all - tutte 43.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.067


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.594 0 0 0 0 0 0 444 492 489 449 342 378
2020/20213.527 392 447 370 449 379 334 435 337 110 103 140 31
2021/2022760 38 96 74 35 26 84 36 27 53 55 50 186
2022/2023845 118 90 20 103 73 184 61 49 63 12 53 19
2023/2024252 37 6 22 12 22 70 12 4 3 5 8 51
2024/20251.095 66 365 172 112 74 263 43 0 0 0 0 0
Totale 21.503